Author

Alok Sahay

Observed names: A. Sahay, Sahay, Alok

Institution: University of Cincinnati

Observed institutions: University of Kentucky, University of Cincinnati, University of Cincinnati Medical Center

ORCID: 0000-0002-8132-022X

Observed ORCID: 0000-0002-8132-022X

OpenAlex ID: A5042839648

A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease

2014 · The Parkinson Study Group QE3 Investigators, M. Flint Beal, et al. · JAMA Neurology · 410

Deterministic center of pressure patterns characterize postural instability in Parkinson’s disease

2005 · Jennifer M. Schmit, Michael A. Riley, et al. · Experimental Brain Research · 224

The modified bradykinesia rating scale for Parkinson's disease: Reliability and comparison with kinematic measures

2011 · Dustin A. Heldman, Joseph P. Giuffrida, et al. · Movement Disorders · 199

Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease

2011 · Alberto J. Espay, Joe P. Giuffrida, et al. · Movement Disorders · 156

Methylphenidate for gait impairment in Parkinson disease

2011 · A.J. Espay, A.K. Dwivedi, et al. · Neurology · 101

Genotype and smoking history affect risk of levodopa‐induced dyskinesias in Parkinson's disease

2006 · Judith A. Strong, Arif Dalvi, et al. · Movement Disorders · 66

Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1

2004 · Yang Tang, Aigang Lu, et al. · Molecular Brain Research · 44

Botulinum toxin type A for Levodopa‐induced cervical dyskinesias in Parkinson's disease: Unfavorable risk‐benefit ratio

2011 · Alberto J. Espay, Jennifer E. Vaughan, et al. · Movement Disorders · 17

274 Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease: a Randomized, Double-blind, Placebo-controlled, Cross-over Study (preliminary Results)

2010 · A. Espay, A. Kumar Dwivedi, et al. · Parkinsonism & Related Disorders

Works count: 10

Citation count: 1,216

H-index: 8

I10-index: 8